Plain-English translation of NCT05992831 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called accelerated intermittent theta burst stimulation (iTBS), which uses magnetic pulses to stimulate a specific area of the brain. The study aims to find the right dose of this treatment to reduce depression and improve cognitive function in people aged 60–85 who have been diagnosed with mild cognitive impairment. Researchers want to understand how many sessions work best before testing the treatment more widely.
Mild cognitive impairment often comes with depression, and current treatments don't work well for everyone. This study exists to figure out the best dose of this non-invasive brain stimulation so that future trials can be more efficient and help people more quickly.
You likely qualify if…
You likely don't qualify if…
You would visit the study site 6 days per week for treatment sessions. During each visit, you would receive 10 sessions of magnetic brain stimulation—some real and some sham (fake), so you won't know which is which. The total length of your participation would involve receiving between 0 and 48 active treatment sessions depending on which dose group you're assigned to. Throughout the study, you'll complete memory and mood tests, have blood drawn, and possibly undergo brain imaging to see how the treatment affects your thinking and brain activity.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
United States